SOPHiA GENETICS (SOPH) president sells 5,024 shares for tax withholding

Rhea-AI Filing Summary

SOPHiA GENETICS SA president Ross Muken sold 5,024 Ordinary Shares in two small open-market transactions to cover taxes on recent equity vesting. On April 6 and 7, 2026, he sold 2,600 shares at a weighted average of $4.8474 and 2,424 shares at $4.8686.

The footnotes state these sales were made to satisfy tax withholding obligations from restricted stock units that vested on April 2 and 3, 2026, under a pre-established Rule 10b5-1 trading plan and were not discretionary trades. After these sales, he continues to hold 698,097 Ordinary Shares directly.

Insights

Equity compensation analyst

Small, pre-planned tax-related sales with large stake retained.

President Ross Muken sold 5,024 Ordinary Shares of SOPHiA GENETICS SA in two open-market transactions at weighted average prices of $4.8474 and $4.8686. The filing shows these sales relate to vesting of restricted stock units.

Footnotes explain the trades were executed to satisfy tax withholding obligations from RSU vesting on April 2 and 3, 2026, under a pre-established Rule 10b5-1 trading plan, so timing is routine rather than opportunistic. After the transactions, Muken still directly owns 698,097 shares, indicating the sales represent only a small portion of his holdings.

Insider Trade Summary 10b5-1

Net Seller: 5,024 shares ($24,405)

Net Sell 2 txns

Insider Muken Ross

Role President

Sold 5,024 shs ($24K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	2,424	$4.8686	$12K
Sale	Ordinary Shares	2,600	$4.8474	$13K

Holdings After Transaction: Ordinary Shares — 698,097 shares (Direct)

Footnotes (1)

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.6150 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.77 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold April 6, 2026: 2,600 shares at $4.8474 Shares sold April 7, 2026: 2,424 shares at $4.8686 Total shares sold: 5,024 shares +3 more

6 metrics

Shares sold April 6, 2026 2,600 shares at $4.8474 Open-market sale of Ordinary Shares

Shares sold April 7, 2026 2,424 shares at $4.8686 Open-market sale of Ordinary Shares

Total shares sold 5,024 shares Net insider sales across two transactions

Shares held after transactions 698,097 shares Direct ownership by Ross Muken following sales

Price range April 6, 2026 $4.77 to $4.98 Weighted average price $4.8474

Price range April 7, 2026 $4.6150 to $4.95 Weighted average price $4.8686

Key Terms

restricted stock units, Rule 10b5-1 trading plan, weighted average price

3 terms

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1 trading plan regulatory

"These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Muken Ross

(Last) (First) (Middle)

C/O SOPHIA GENETICS INC.

401 PARK DRIVE, FLOOR 5

(Street)

BOSTON MASSACHUSETTS 02215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/06/2026		S		2,600(1)	D	$4.8474(2)	700,521	D
Ordinary Shares	04/07/2026		S		2,424(1)	D	$4.8686(3)	698,097	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.6150 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.77 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-fact for Ross Muken	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did SOPHiA GENETICS (SOPH) report for Ross Muken?

SOPHiA GENETICS reported that President Ross Muken sold 5,024 Ordinary Shares in two open-market transactions. These trades were linked to tax withholding on vested restricted stock units and executed under a pre-established Rule 10b5-1 trading plan.

How many SOPHiA GENETICS (SOPH) shares did Ross Muken sell and at what prices?

Ross Muken sold 2,600 Ordinary Shares at a weighted average price of $4.8474 and 2,424 shares at a weighted average price of $4.8686. The trades were executed over multiple transactions within disclosed price ranges.

Why did SOPHiA GENETICS president Ross Muken sell shares of SOPH?

The filing states Muken sold the shares to satisfy tax withholding obligations from restricted stock units that vested on April 2 and 3, 2026. These tax-related sales were carried out under a pre-established Rule 10b5-1 trading plan.

Were Ross Muken’s SOPHiA GENETICS share sales discretionary trades?

No. The footnotes specify the sales were not discretionary. They were executed under a pre-established Rule 10b5-1 trading plan and intended to cover tax withholding obligations arising from the vesting of restricted stock units.

How many SOPHiA GENETICS (SOPH) shares does Ross Muken hold after these sales?

After selling a total of 5,024 Ordinary Shares, Ross Muken directly holds 698,097 Ordinary Shares. This indicates the reported sales represent only a small fraction of his overall direct ownership position in SOPHiA GENETICS.

What price ranges applied to Ross Muken’s SOPHiA GENETICS share sales?

For the April 6, 2026 sale, shares traded between $4.77 and $4.98. For the April 7, 2026 sale, the range was $4.6150 to $4.95. Reported prices are weighted averages across multiple individual transactions.